Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody

Thomas J. Gniadek, Patricia A. Arndt, Regina M. Leger, Daniel Zydowicz, Edward Y. Cheng, Nicole D. Zantek

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

BACKGROUND: Drug-induced immune hemolytic anemia (DIIHA) is rare, but potentially life-threatening. A high index of clinical suspicion is required for diagnosis, since the number of medications known to induce DIIHA continues to expand. Additionally, in vitro antibody reactivity against reagent additives has been reported, which may complicate test interpretation. CASE REPORT: A 61-year-old group A, D+ woman with a history of negative antibody detection tests developed hemolytic anemia on Postoperative Day 7 after repeat incision and drainage of a chronically infected right knee prosthesis. She was treated with multiple antibiotics in the postoperative period, including three cephalosporins and vancomycin intravenously as well as vancomycin and gentamicin-containing intraarticular cement spacers. STUDY DESIGN AND METHODS: A workup for possible DIIHA was performed. Testing was performed using vancomycin and cephalosporin antibiotics. Initially, gentamicin injection solution was used for testing, followed by testing with its component ingredients. RESULTS: A vancomycin antibody was detected and anemia resolved after vancomycin was discontinued. Reactivity was seen when gentamicin injection solution was used for testing, raising the possibility of a gentamicin antibody as well. However, testing with purified gentamicin as well as methylparaben and propylparaben demonstrated a paraben antibody that reacted with the paraben-containing gentamicin solution. The patient also demonstrated an anti-N. Neither the paraben antibody nor the anti-N appeared to cause in vivo hemolysis. CONCLUSION: This is the second reported case of DIIHA associated with anti-vancomycin. It is the fourth report describing a paraben antibody.

Original languageEnglish (US)
Pages (from-to)181-188
Number of pages8
JournalTransfusion
Volume58
Issue number1
DOIs
StatePublished - Jan 2018

Bibliographical note

Funding Information:
Research funding, royalties, or other support from Verax Biomedical, Inc., Terumo BCT, Sekisui Diagnostics, AstraZeneca, and Bayer HealthCare (NDZ) and Innomed, Norvartis, and Musculoskeletal Transplant Foundation (EYC). Financial interest in Endo International PLC (NDZ). The other authors have disclosed no conflicts of interest.

Funding Information:
The authors acknowledge the late Dr George Garratty, American Red Cross Blood Services, Southern California Region, for his contributions to the case and the field of drug-induced immune hemolytic anemia.

Publisher Copyright:
© 2017 AABB

Fingerprint Dive into the research topics of 'Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody'. Together they form a unique fingerprint.

Cite this